Medication nonadherence secondary to drug-induced memory loss

Consultant Pharmacist

Volumn 25, Issue 2, 2010, Pages 117-121

  Nye, Ann Marie ^a,b   Clinard, Valerie B ^a   Barnes, Connie L ^a  

^a CAMPBELL UNIVERSITY   (United States)

^b EAST CAROLINA UNIVERSITY   (United States)

Author keywords

Adherence; Antimuscarinic agents; Cognitive dysfunction; Drug induced memory loss; Memory loss; Overactive bladder

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ATORVASTATIN; BENAZEPRIL; FLUTICASONE PROPIONATE; GABAPENTIN; HUMAN INSULIN; HYDROCHLOROTHIAZIDE; INSULIN GLARGINE; LANSOPRAZOLE; METFORMIN; OXYBUTYNIN; PARACETAMOL; SALBUTAMOL;

AGED; ALLERGIC RHINITIS; ARTHRITIS; ARTICLE; ASTHMA; BEDTIME DOSAGE; CASE REPORT; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ESOPHAGITIS; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MEMORY DISORDER; MINI MENTAL STATE EXAMINATION; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVERACTIVE BLADDER; PATIENT COMPLIANCE; WHEEZING;

AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; MANDELIC ACIDS; MEDICATION ADHERENCE; MEMORY DISORDERS; MUSCARINIC ANTAGONISTS; PHARMACISTS; PROFESSIONAL ROLE; URINARY BLADDER, OVERACTIVE;

EID: 77749258872     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2010.117     Document Type: Article

References (22)

1. Katz IR, Sands LP, Bilker W et al. Identification of medications that cause cognitive impairment in older people: the case of oxybutynin chloride. J Am Geriatr Soc 1998;46:8-13.
2. Fiek DM, Cooper JW, Wade WE et al. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 2003;163:2716-24.
3. Carter BL, Ernst ME, Cohen JD. Hydrochlorothiazide versus chlorthalidone: evidence supporting their interchangeability. Hypertension 2004;43:4-9.
4. Dalen JE. Aspirin to prevent heart attack and stroke: what's the right dose? Am J Med 2006;119:198-202.
5. American Diabetes Association. Standards of medical care in diabetes - 2009. Diabetes Care 2009;32 suppl 1:13-61.
6. Glucophage [package insert]. Princeton, NJ: Bristol-Myers Squibb Co; 2009.
7. Scheife R, Takeda M. Central nervous system safety of anticholinergic drugs for the treatment of overactive bladder in the elderly. Clin Ther 2005;27:144-53.
8. Kay GG, Abou-Donia MB, Messer WS et al. Antimuscarinic drugs for overactive bladder and their potential effects on cognitive function in older patients. J Am Geriatr Soc 2005;53:2195-2201.
9. Kay GG, Ebinger U. Preserving cognitive function for patients with overactive bladder: evidence for a differential effect with darifenacin. Int J Clin Pract 2008;62:1792-800.
10. Chutka DS, Takahashi PY, Hoel RW. Inappropriate medications for elderly patients. Mayo Clin Proc 2004;79:122-39.
11. Gulsun M, Pinar M, Sabanci U. Psychotic disorder induced by oxybutynin: presentation of two cases. Clin Drug Invest 2006;26:603-6.
12. Klausner AP, Steers WD. Antimuscarinics for the treatment of overactive bladder: a review of central nervous system effects. Curr Urol Rep 2007;8:441-7.
13. Staskin DR. Overactive bladder in the elderly: a guide to pharmacological management. Drugs Aging 2005;22:1013-28.
14. Ancelin ML, Artero S, Porter F et al. Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study. BMJ 2007;332:455-9.
15. Lechevallier-Michel N, Molimard M, Dartigues JF et al. Drugs with anticholinergic properties and cognitive performance in the elderly: results from the PAQUID study. Br J Clin Pharmacol 2005;59:143-51.
16. Kay G, Crook T, Rekeda L et al. Differential effects of the antimuscarinic agents darifenacin and oxybutynin ER on memory in older subjects. Eur Urol 2006;50:317-26.
17. George J, Elliott RH, Stewart DC. A systematic review of interventions to improve medication taking in elderly patients prescribed multiple medications. Drugs Aging 2008;25:307-24.
18. Sabate E, ed. Adherence to Long-term Therapies: Evidence for Action. Geneva, Switzerland: World Health Organization; 2003.
19. Vik SA, Maxwell CJ, Hogan DB. Measurement, correlates, and health outcomes of medication adherence among seniors. Ann Pharmacother 2004;38:303-12.
20. Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998;20:764-71.
21. Berman-Evans B. AIDES to improving medication adherence in older adults. Geriatr Nurs 2006;27:174-82.
22. Ruppar TM, Conn VS, Russell CL. Medication adherence interventions for older adults: literature review. Res Theory Nurs Pract 2008;22:114-47.